Published in
Springer (part of Springer Nature), Journal of Cancer Research and Clinical Oncology, 1(142), p. 317-324
DOI: 10.1007/s00432-015-2050-y
Links
Tools
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation
Journal article published in 2015 by
Christian Pfrepper,
Anne Klink,
Gerhard Behre,
Thomas Schenk,
Georg-Nikolaus Franke,
Madlen Jentzsch,
Sebastian Schwind,
Haifa-Kathrin Al-Ali 
,
Andreas Hochhaus,
Dietger Niederwieser,
Herbert Gottfried Sayer
,
Andreas Hochhaus,
Dietger Niederwieser,
Herbert Gottfried Sayer
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 